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http://dx.doi.org/10.1016/j.jmii.2013Background: Kocuria kristinae is a Gram-positive microorganism, which has rarely been re-
ported as a pathogen that causes infection in humans. Recently, a few studies had concluded
that this pathogen can indeed cause infection in immunocompromised hosts. However, the
number of reports on K. kristinae infection in pediatric patients is still relatively limited.
Methods: Clinical data on pediatric patients who had K. kristinae cells isolated from their
blood specimens during the period from January 2008 to May 2012 in a tertiary-care hospital
in northern Taiwan were gathered and analyzed.
Results: Among 12 patients with K. kristinae cells isolated from their blood specimens, labo-
ratory test results confirmed seven to have K. kristinae bloodstream infection. Six of them
were premature babies, and one had acute leukemia. The infections were all healthcare asso-
ciated. All the six premature babies had clinical presentation of sepsis and were inserted with
percutaneous central venous catheters. One patient had two sets of blood culture positive for
K. kristinae infection, and two premature patients had two sets of K. kristinae isolated, one
from blood culture and the other from catheter tip culture, both of which were done at the
same time. The leukemic child was inserted with a Broviac catheter and had K. kristinae iso-
lated from both blood specimen and Broviac catheter. In the remaining five patients, K. kris-
tinae infection was considered to be contaminant because they had only one set of positive
blood culture and had other recognized infections.
Conclusion: K. kristinae can cause infections in premature babies and immunocompromised
pediatric patients using long-term intravenous catheters. Therefore, K. kristinae should beof Pediatrics, Mackay Memorial Hospital, Number 92, Section 2, Zhongshan North Road, Taipei 10449,
org.tw (N.-C. Chiu).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
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Kocuria kristinae infection in children 81considered as a true pathogen and proper treatment should be provided to all susceptible
pediatric patients.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Kocuria kristinae is a Gram-positive microorganism found
on human skin and mucosa. Previously, they were classified
under the genus Micrococcus, and regarded as a harmless
normal skin microorganism. However, they have now been
reclassified under the new genus Kocuria.1 There are some
reports of K. kristinae-associated infections in patients,
especially those with malignancies or other immunosup-
pressed states.2e9 The number of documented cases of in-
fections is rare and the clinical pathogenic potency of K.
kristinae is still doubtful. In addition, the number of re-
ported patients in the pediatric group is even more limited.
Therefore, we performed this study in order to better
understand the clinical characteristics of K. kristinae
bacteremia in pediatric patients.Materials and methods
Patients’ information
Data on all patients in the pediatric group with K. kristinae
cells isolated from their blood culture during the period
from January 2008 to May 2012 were retrieved from the
microbiology laboratory database. We collected their clin-
ical information from related medical records, including
age, sex, underlying disease, comorbidity, clinical presen-
tation, invasive procedure, infection source, laboratory
data, management, and outcome. This study was approved
by the Institutional Review Board of the Mackay Memorial
Hospital (12MMNIS162).Definition
Bloodstream infection is confirmed in the laboratory tests if
a recognized pathogen could be cultured from one or more
blood cultures and the organism cultured from blood sam-
ples was not related to an infection at another site. An
episode of bacteremia was defined as the condition of
having more than one blood culture positive for K. kristinae
that contributed to clinical sepsis. If there was only one
positive blood culture, another positive culture should be
obtained directly from an intravenous catheter or the
clinical significance was otherwise evident.10 The clinical
significance of neonatal sepsis was defined as follows: (1) at
least one of the following clinical signs or symptoms with no
other recognized cause: fever, hypothermia, apnea, or
bradycardia; (2) no apparent infection at another site; and
(3) receiving treatment for sepsis.11,12 Episodes associated
with contaminants were defined as the isolation of K.
kristinae from a single blood culture and where criteria for
laboratory-confirmed bloodstream infection were not met.The criteria for confirming catheter-related bacteremia
were: (1) isolation of the same microorganism from blood
and exudates from the catheter’s exit site or specimens
from the catheter lumen with signs of inflammation; and (2)
isolation of the same microorganism from blood and the
catheter tip upon removal of the catheter.13
Healthcare-associated infection was a localized or sys-
temic condition resulting from an adverse reaction to the
presence of an infectious agent or its toxin. There must be
no evidence that the infection was present or that the
bacteria were incubating at the time of admission to the
acute-care setting.10
Microbiology
One set of blood culture was obtained from most of
the patients. A catheter tip culture might be done simul-
taneously if the catheter was removed immediately.
Approximately 0.5e3 mL of blood was drawn after steril-
izing the skin. The blood samples were then added into BD
BACTEC Peds Plus culture vials (Becton Dickinson Company,
Benex Limited, Shannon, Ireland). Blood culture specimens
were processed by the VITEK 2 system (bioMe´rieux, Marcy-
l’E´toile, France) with VITEK 2 Gram-positive identification
card used to confirm Gram-positive bacterial identification.
Results
During the study period, a total of 12 pediatric patients with
blood cultures of K. kristinae were included for analysis. The
demographic data and clinical characteristics of the patients
are summarized in Tables 1 and 2. Seven patients (Case
Numbers 1e7) were regarded as having laboratory-confirmed
K. kristinae bloodstream infection, whereas K. kristinae
infection was considered to be a contaminant in the
remaining five patients (Case Numbers 8e12).
Among the laboratory-confirmed bloodstream infection
group, six of them were premature babies (Case Numbers
1e6) and one patient had acute leukemia (Case Number 7).
The six premature patients had risk factors for infection
including small for gestation age, low birth weight, pro-
longed hospital stay, use of intravascular devices and res-
piratory support, and total parenteral nutrition. They all
had a clinical presentation of sepsis, were inserted with
percutaneous central venous catheters, and received anti-
biotic treatment. Three premature babies (Case Numbers
1e3) had K. kristinae cells isolated from their only set of
blood culture, and a simultaneous catheter culture was not
performed. One premature patient (Case Number 4)
had two sets of blood culture, done in 2 successive days,
positive for K. kristinae. Two premature patients (Case
Numbers 5 and 6) had two sets of K. kristinae isolated, one
from blood culture and the other from catheter tip culture,
Table 1 Demographic data of 12 patients with Kocuria kristinae isolated from blood cultures
Case Sex/
Age (mo)
Diagnosis at admission Underlying
disease
Concomitant
disease
Isolation site Intravascular
devices
Healthcare-
associated
infection
Clinical presentation
Group 1 1 M/1.4 Prematurity, GA 26 þ 3 wk Prematurity No Blood PCVC Yes Apnea, bradycardia
2 M/0.6 Prematurity, GA: 27 þ 3 wk Prematurity No Blood PCVC Yes Apnea, bradycardia
3 F/0.7 Prematurity, GA: 28 þ 1 wk Prematurity No Blood PCVC Yes Apnea, bradycardia
4 F/1.1 Prematurity, GA 25 þ 4 wk Prematurity No Blood  2 PCVC Yes Desaturation,
thrombocytosis
5 F/0.6 Prematurity, GA 31 þ 1 wk Prematurity No Blood & catheter tip PCVC Yes Apnea, bradycardia
6 F/0.6 Prematurity, GA 31 þ 1 wk Prematurity No Blood & catheter tip PCVC Yes Apnea, bradycardia
7 F/2.5 Infantile acute leukemia Leukemia No Blood & Broviac Broviac Yes Neutropenic fever
Group 2 8 F/4.4 UTI No UTI: E. coli Blood Peripheral catheter No Fever to 40 C for 3 d
9 M/13.8 UTI No UTI: E. coli Blood Peripheral catheter No Fever to 39 C for 1 d
10 F/33.9 Bronchopneumonia No Pneumonia Blood Peripheral catheter No Fever to 39 C for 4 d
11 F/9.0 Acute bronchiolitis No Febrile convulsion Blood Peripheral catheter No Fever to 40 C for 3 d
12 F/16.9 Acute pharyngitis No Viral exanthem Blood Peripheral catheter No Fever to 40 C for 4 d
E. coli Z Escherichia coli; F Z female; GA Z gestation age; M Z male; PCVC Z percutaneous central venous catheter; UTI Z urinary tract infection.
Table 2 Treatment and outcomes of 12 patients with Kocuria kristinae isolated from blood cultures
Case Hospital
duration (d)
Isolation time
after admission (d)
Antibiotic regimen Antibiotic
treatment
course (d)
Respiratory
support
Total parenteral
nutrition
Empirical antibiotic
indication
Outcome
Group 1 1 85 43 Vancomycin, Ceftazidime 10 Yes Yes Clinical sepsis Recovery
2 79 17 Vancomycin 10 Yes Yes Clinical sepsis Recovery
3 69 21 Vancomycin, Ceftazidime 10 Yes Yes Clinical sepsis Recovery
4 97 33 Oxacillin, Vancomycin 9 Yes Yes Clinical sepsis Recovery
5 66 18 Vancomycin, Cefotaxime 12 Yes Yes Clinical sepsis Recovery
6 46 20 Vancomycin, Cefotaxime 10 Yes Yes Clinical sepsis Recovery
7 88 19 Vancomycin, Piperacillin/
Tazobactam
10 No No Neutropenic fever Recovery
Group 2 8 8 0 Cefazolin 7 No No UTI Recovery
9 7 0 Gentamicin, Cefazolin 7 No No UTI Recovery
10 5 0 Amoxicillin/Clavulanate 9 No No Pneumonia Recovery
11 3 0 No 0 No No No Recovery
12 4 0 No 0 No No No Recovery
UTI Z urinary tract infection.
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Kocuria kristinae infection in children 83both of which were done at the same time. The leukemic
patient had a prolonged hospital stay and was inserted with
a Broviac catheter (C. R. Bard, Inc., New Jersey, USA). She
developed a neutropenic fever and had K. kristinae isolated
from her blood specimen, Broviac catheter, and urine
specimen. All seven episodes were healthcare-associated
infections; three were proved to be catheter-related
bacteremia.
These seven patients developed K. kristinae bacteremia
within 17e43 days (24.4  9.8) after their admission. These
patients had a mean white blood cell count of 7768  4319/
mL, C-reactive protein level of 2.65  1.44 mg/dL, and
platelet count of 143,000  76,000/mL. The mean duration
of use of intravascular devices was 18.7  8.4 days. Six
patients, except Case Number 7, received ventilator sup-
port (endotracheal tube and nasal continuous positive
airway pressure) and the mean duration for the support was
24.6  10.9 days. These episodes were mainly treated with
vancomycin for 9e12 days (10.1  0.9 days). Besides, their
intravenous devices were all removed. The hospitalization
courses were 46e97 days (75.7  16.9 days). All the K.
kristinae infections were successfully managed and there
was no infection-related mortality.
The second group was thought to be a skin contaminant.
All the five patients had associated comorbidity, including
two urinary tract infections (Case Numbers 8 and 9), one
pneumonia (Case Number 10), one acute bronchiolitis with
febrile convulsion (Case Number 11), and one viral exan-
thema (Case Number 12). The two patients with urine
culture positive for Escherichia coli infection and the one
with pneumonia received antibiotic therapy for 7e9 days,
and other two cases did not. Their second blood cultures
were all negative for K. kristinae.Discussion
K. kristinae is a facultative anaerobic Gram-positive bacte-
rium that occurs in tetrads and produces pale cream
nonhemolytic colonies on blood agar.7 This bacterium used
to be a member of the Micrococcus family. They have been
identified as common skin and oral flora in humans. Ac-
cording to the Centers for Disease Control and Prevention/
National Healthcare Safety Network surveillance definition
of healthcare-associated infections, Micrococcus spp. are
thought to be common skin contaminants.10 Recently,
Stackebrandt et al1 made a taxonomic revision of this class
of microorganisms and some strains were reclassified
under the new genus Kocuria. At present, K. kristinae can be
identified by the new version of the VITEK 2 system.14 Pre-
viously, there was a possible misidentification of coagulase-
negative Staphylococci as Kocuria spp. when using the old
version of the automated identification system in the hos-
pital laboratory. However, this misidentification is avoidable
when using the recent versions of this system.7,14
Only a few cases of K. kristinae infection were found in
the related literature. Infection due to K. kristinae was first
reported in an ovarian cancer patient with catheter-related
bacteremia.2 In addition, K. kristinae infection was
also reported for acute cholecystitis,3 brain abscess,5
infective endocarditis,6 central venous catheter-related
bacteremia among immunocompromised hosts receivingtotal parenteral nutrition,7 and dialysis-related perito-
nitis.8,9 In our patients, the K. kristinae infections are
mainly found in premature babies and patients with ma-
lignancy. They were all with percutaneous central venous
catheters. This finding is similar to the previous reports that
most K. kristinae infections are catheter related and in
immunocompromised patients.2e7
Intravascular devices can be seen in most patients with
primary bloodstream infections. Using intravascular devices
in premature babies and in immunocompromised patients is
the most powerful risk factor for bloodstream infection.
Blood cultures are usually performed when clinical sepsis is
suspected, but many culture results may be negative,
especially in neonates. Stoll et al15 reported that although
the actual number of very low-birth-weight newborns with
culture-proven infection was only 1.9%, 50% of the babies
were prescribed antibiotics by clinicians on the basis of
clinical and risk factors. This is because the behavior of the
bacterium is not constant, and the sensitivity of the blood
culture increases with the number of cultures drawn and
the volume of the sample.16 Neonates are at high risk of
acquiring healthcare-associated infections because of
impaired host-defense mechanisms, limited amounts of
protective endogenous flora on skin at time of birth,
reduced barrier function of their skin, and use of invasive
procedures and devices.17 Neonates with a gestational age
less than 30 weeks, birth body weight less than 1500 g, and
on respiratory support, with peripheral catheter, central-
long catheter, total parenteral nutrition, and prolonged
hospital stays have a greater risk of developing sepsis.18
The risk factors for infection, except prematurity but
including other underlying disorders, which impair host-
defense mechanisms are neutropenia, end-stage renal dis-
ease, and the administration of certain drugs such as cor-
ticosteroids and other immune suppressants.19 The K.
kristinae infections generally occur during a long hospital
course. Our patients developed the infection within 17e43
days after their admission and fulfilled the definition of
healthcare-associated infections.10,20 Even though some of
our patients had only one set of positive culture for K.
kristinae, we still think of it as a potentially infectious
pathogen in these special groups.
Because of the limited number of reports available
regarding this infection, there are no guidelines for man-
aging it. In our patients, they were mainly treated with
vancomycin due to the underlying diseases. The K. kristinae
infections have been managed successfully with a number
of different antimicrobial drugs according to previous re-
ports.7 In the literature, isolated K. kristinae may be sen-
sitive to b-lactams, quinolones, lincosamides, co-
trimoxazole, glycopeptides, streptogramins, fusidic acid,
or linezolid so far, but may or may not be resistant to
oxacillin/methicillin.21 Treatment has been successful
using monotherapy with oxacillin, vancomycin, piper-
acillin/tazobactam, and ciprofloxacin and combination
therapy with teicoplanin and vancomycin, ciprofloxacin,
and clindamycin as well as ceftriaxone and ofloxacin.7
Previous reports have also suggested that the removal of
the intravascular catheter is necessary due to catheter-
related, healthcare-associated infection characteris-
tics.2,6,7 The infection course and outcome are usually good
after antibiotic treatment and catheter removal.
84 H.-M. Chen et al.Contamination of K. kristinae may occur in immuno-
competent children; however, if the contamination rate
is relatively high, unnecessary antibiotic usage and
longer hospital stay with more hospital-care costs will in-
crease.22 Three of our K. kristinae contaminant patients
only received antibiotic therapy for other bacterial in-
fections. The other two did not receive prescribed antibi-
otic agents because they were considered to be viral
infections. Physicians need to make a judgment on whether
the isolated K. kristinae cells represent a true infection
or not.
Our study has several limitations that are worth noting.
First, although the number of children studied is larger than
previous reports, it is still small and premature patients are
the major part of this study. A larger patient number and
broader spectrum of patients are needed for further eval-
uation. Second, it was difficult to distinguish between true
K. kristinae infections and contaminant organisms. The
gold standard for diagnosing an infection is to get two blood
cultures from separate sites at sepsis evaluation. The
Clinical and Laboratory Standards Institute guidelines
recommend that a single set of cultures should never be
drawn initially in patients with clinical suspicion of sepsis.
Independently drawn venipuncture helps to distinguish
between contaminant organisms.22 However, usually only
one set of blood culture was performed in the newborns.
Adequate blood sampling volume is also an important factor
for detecting a bloodstream organism.22 This could be
difficult in the pediatric group especially in premature ba-
bies. It is difficult to obtain adequate blood samples in this
group and the average volume of blood placed in a blood
culture bottle is <0.5 mL, making this test markedly less
sensitive.12 Third, we used only the VITEK 2 system to
confirm the identity of bacteria and lack of molecular
typing of this pathogen. In addition, we did not perform a
drug-sensitivity test to provide guidance on antibiotic
choice. The best identification method for K. kristinae and
the best choice of antibiotics still need further studies.
In conclusion, we should not underestimate the possi-
bility of K. kristinae infection when blood culture shows a
positive result particularly in pediatric immunocompro-
mised patients, including newborns, with intravenous
catheter. Therefore, K. kristinae should be considered as a
true pathogen and proper treatment should be provided to
all susceptible pediatric patients.
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